Business · 22/08/2014
FDA Reopens Public Docket for Comments on Safety and Innovation Act Action Plan
The FDA is reopening a public docket for comments on its action plan for the Food and Drug Administration Safety and Innovation Act (FDASIA), following the issuance of the required action plan as mandated by section 907 of the law.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →